BioMerieux
在场
Institut Merieux 拥有 7家子公司，其中包括 Advanced BioScience Laboratories、BioMerieux 和 BioMerieux Americas。
他们在：
高管
查看带有其 32 名主要高管的组织结构图
BioMerieux 搜索最多的简介
- Pierre Boulud, Chief Executive Officer
- Alexandre Merieux, Chairman of the Board
- Marie-Paule Kieny, Independent Director
创建提醒
跟踪 BioMerieux 的高管变动
药店
Institut Merieux 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
BioMerieux 的最新新闻稿
- BIOFIRE® FILMARRAY® Tropical Fever Panel, a syndromic PCR test targeting causes of tropical fever infections, receives U.S. FDA Special 510(k) clearance
- Communiqués de presse
- Third-Quarter 2024 Business Review
- bioMérieux receives CE-marking for VIDAS® VITAMIN B12 TOTAL, a blood test to measure total Vitamin B12 concentration
- Press Releases
- Press Releases
- First-Half 2024 Results
- Extremely promising clinical trial results for the high-sensitivity Point-of-Care (POC) cardiac troponin I test of our partner SpinChip Diagnostics
- bioMérieux receives U.S. FDA Special 510(k) clearance and CLIA-waiver for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini
- bioMérieux receives US FDA 510(k) clearance for its AST System VITEK® REVEAL™
- View more press releases Close
关于 BioMerieux 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Pierre Boulud 
